vs
Fortrea Holdings Inc.（FTRE）与Natera, Inc.（NTRA）财务数据对比。点击上方公司名可切换其他公司
Natera, Inc.的季度营收约是Fortrea Holdings Inc.的1.0倍（$665.5M vs $660.5M）。Natera, Inc.净利率更高（7.1% vs -4.9%，领先12.0%）。Natera, Inc.同比增速更快（39.8% vs -5.2%）。Fortrea Holdings Inc.自由现金流更多（$121.6M vs $37.8M）。过去两年Natera, Inc.的营收复合增速更高（34.5% vs -0.1%）
Fortrea Holdings Inc.是一家总部位于美国北卡罗来纳州达勒姆、注册地为特拉华州的合同研究组织，业务覆盖90个国家，主要服务制药、生物技术和医疗器械行业客户，为相关领域的研发提供专业支持。
Natera是总部位于美国得克萨斯州奥斯汀的临床基因检测企业，主打无创游离DNA（cfDNA）检测技术，业务覆盖女性健康、肿瘤及器官健康三大核心赛道。其自研专利技术结合前沿分子生物学手段与生物信息学工具矩阵，可实现单管血液样本中低至单个分子级别的高灵敏度检测。
FTRE vs NTRA — 直观对比
营收规模更大
NTRA
是对方的1.0倍
$660.5M
营收增速更快
NTRA
高出45.0%
-5.2%
净利率更高
NTRA
高出12.0%
-4.9%
自由现金流更多
FTRE
多$83.8M
$37.8M
两年增速更快
NTRA
近两年复合增速
-0.1%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $660.5M | $665.5M |
| 净利润 | $-32.5M | $47.3M |
| 毛利率 | — | — |
| 营业利润率 | -2.1% | -3.4% |
| 净利率 | -4.9% | 7.1% |
| 营收同比 | -5.2% | 39.8% |
| 净利润同比 | 46.9% | 187.9% |
| 每股收益（稀释后） | $-0.25 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FTRENTRA
| Q4 25 | $660.5M | $665.5M | ||
| Q3 25 | $701.3M | $592.2M | ||
| Q2 25 | $710.3M | $546.6M | ||
| Q1 25 | $651.3M | $501.8M | ||
| Q4 24 | $697.0M | $476.1M | ||
| Q3 24 | $674.9M | $439.8M | ||
| Q2 24 | $662.4M | $413.4M | ||
| Q1 24 | $662.1M | $367.7M |
净利润FTRENTRA
| Q4 25 | $-32.5M | $47.3M | ||
| Q3 25 | $-15.9M | $-87.5M | ||
| Q2 25 | $-374.9M | $-100.9M | ||
| Q1 25 | $-562.9M | $-66.9M | ||
| Q4 24 | $-61.2M | $-53.8M | ||
| Q3 24 | $-27.9M | $-31.6M | ||
| Q2 24 | $-138.4M | $-37.5M | ||
| Q1 24 | $-101.0M | $-67.6M |
营业利润率FTRENTRA
| Q4 25 | -2.1% | -3.4% | ||
| Q3 25 | -1.2% | -16.5% | ||
| Q2 25 | -46.5% | -20.2% | ||
| Q1 25 | -79.9% | -15.8% | ||
| Q4 24 | -8.0% | -13.6% | ||
| Q3 24 | -2.7% | -8.9% | ||
| Q2 24 | -7.7% | -10.6% | ||
| Q1 24 | -5.6% | -20.2% |
净利率FTRENTRA
| Q4 25 | -4.9% | 7.1% | ||
| Q3 25 | -2.3% | -14.8% | ||
| Q2 25 | -52.8% | -18.5% | ||
| Q1 25 | -86.4% | -13.3% | ||
| Q4 24 | -8.8% | -11.3% | ||
| Q3 24 | -4.1% | -7.2% | ||
| Q2 24 | -20.9% | -9.1% | ||
| Q1 24 | -15.3% | -18.4% |
每股收益（稀释后）FTRENTRA
| Q4 25 | $-0.25 | $0.36 | ||
| Q3 25 | $-0.17 | $-0.64 | ||
| Q2 25 | $-4.14 | $-0.74 | ||
| Q1 25 | $-6.25 | $-0.50 | ||
| Q4 24 | $-0.68 | $-0.41 | ||
| Q3 24 | $-0.31 | $-0.26 | ||
| Q2 24 | $-1.55 | $-0.30 | ||
| Q1 24 | $-1.13 | $-0.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $174.6M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $563.5M | $1.7B |
| 总资产 | $2.7B | $2.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FTRENTRA
| Q4 25 | $174.6M | — | ||
| Q3 25 | $131.3M | $1.0M | ||
| Q2 25 | $81.2M | $16.0M | ||
| Q1 25 | $101.6M | $17.8M | ||
| Q4 24 | $118.5M | $22.7M | ||
| Q3 24 | $105.3M | $29.5M | ||
| Q2 24 | $126.2M | $90.3M | ||
| Q1 24 | $92.8M | $69.1M |
股东权益FTRENTRA
| Q4 25 | $563.5M | $1.7B | ||
| Q3 25 | $580.8M | $1.3B | ||
| Q2 25 | $589.2M | $1.2B | ||
| Q1 25 | $858.8M | $1.2B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | $1.5B | $878.5M | ||
| Q2 24 | $1.5B | $836.5M | ||
| Q1 24 | $1.6B | $794.1M |
总资产FTRENTRA
| Q4 25 | $2.7B | $2.4B | ||
| Q3 25 | $2.7B | $1.8B | ||
| Q2 25 | $2.8B | $1.8B | ||
| Q1 25 | $3.1B | $1.7B | ||
| Q4 24 | $3.6B | $1.7B | ||
| Q3 24 | $3.7B | $1.6B | ||
| Q2 24 | $3.6B | $1.5B | ||
| Q1 24 | $4.2B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $129.1M | $73.9M |
| 自由现金流经营现金流 - 资本支出 | $121.6M | $37.8M |
| 自由现金流率自由现金流/营收 | 18.4% | 5.7% |
| 资本支出强度资本支出/营收 | 1.1% | 5.4% |
| 现金转化率经营现金流/净利润 | — | 1.56× |
| 过去12个月自由现金流最近4个季度 | $88.3M | $109.1M |
8季度趋势，按日历期对齐
经营现金流FTRENTRA
| Q4 25 | $129.1M | $73.9M | ||
| Q3 25 | $86.8M | $59.4M | ||
| Q2 25 | $21.8M | $37.6M | ||
| Q1 25 | $-124.2M | $44.5M | ||
| Q4 24 | $17.1M | $52.9M | ||
| Q3 24 | $-2.4M | $51.8M | ||
| Q2 24 | $273.7M | $4.0M | ||
| Q1 24 | $-25.6M | $27.0M |
自由现金流FTRENTRA
| Q4 25 | $121.6M | $37.8M | ||
| Q3 25 | $79.5M | $37.0M | ||
| Q2 25 | $14.3M | $11.7M | ||
| Q1 25 | $-127.1M | $22.6M | ||
| Q4 24 | $13.9M | $34.8M | ||
| Q3 24 | $-10.6M | $35.5M | ||
| Q2 24 | $262.5M | $-7.7M | ||
| Q1 24 | $-34.9M | $6.7M |
自由现金流率FTRENTRA
| Q4 25 | 18.4% | 5.7% | ||
| Q3 25 | 11.3% | 6.2% | ||
| Q2 25 | 2.0% | 2.1% | ||
| Q1 25 | -19.5% | 4.5% | ||
| Q4 24 | 2.0% | 7.3% | ||
| Q3 24 | -1.6% | 8.1% | ||
| Q2 24 | 39.6% | -1.9% | ||
| Q1 24 | -5.3% | 1.8% |
资本支出强度FTRENTRA
| Q4 25 | 1.1% | 5.4% | ||
| Q3 25 | 1.0% | 3.8% | ||
| Q2 25 | 1.1% | 4.7% | ||
| Q1 25 | 0.4% | 4.3% | ||
| Q4 24 | 0.5% | 3.8% | ||
| Q3 24 | 1.2% | 3.7% | ||
| Q2 24 | 1.7% | 2.8% | ||
| Q1 24 | 1.4% | 5.5% |
现金转化率FTRENTRA
| Q4 25 | — | 1.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
